MetaCap

Microbot Medical (MBOT) vs InspireMD (NSPR)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Microbot Medical (MBOT) has outperformed InspireMD (NSPR) over the past year, losing 62.8% versus a loss of 72.0%. Over five years, NSPR leads with a -85.1% price change compared with -87.4% for MBOT. Microbot Medical is the larger company by market cap ($45.7 million vs $29.2 million), about 1.6 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

MBOT-62.84%NSPR-72.02%
+62%-11%-84%
Nov 21, 20251 yearNov 20, 2026
MBOT-88.67%NSPR-85.52%
+31%-32%-94%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

MBOT versus NSPR key metrics
MetricMBOTNSPR
Share price$0.68$0.54
Market cap$45.67M$29.23M
1-day change-8.52%-12.97%
YTD return-66.00%-69.66%
1-year return-62.84%-72.02%
5-year return-87.43%-85.12%
EPS (TTM)$-0.27$-0.57
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$8.98M
Revenue growth (YoY)—+28.11%
Net income (latest FY)$-13.14M$-48.79M
Gross margin—29.50%
Operating margin—-552.56%
Net margin—-543.33%
52-week high$2.86$2.17
52-week low$0.52$0.43
Distance from 52-week high-76.22%-75.12%
Analyst consensusstrong_buynone
Avg. price target upside+830.88%+516.67%
Average volume922.53K234.68K
Shares outstanding67.16M54.13M
Employees43127
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Microbot Medical

MBOT stock →

Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space.

Health Care · Medical/Dental Instruments · 43 employees

About InspireMD

NSPR stock →

InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System; and SwitchGuard neuroprotection system to provide flow reversal of cerebral protection in carotid interventions, as well as treating acute stroke with tandem lesions.

Health Care · Medical/Dental Instruments · 127 employees

MBOT vs NSPR FAQ

Which is bigger, Microbot Medical or InspireMD?

Microbot Medical (MBOT) is larger, with a market capitalization of $45.67M compared with $29.23M for InspireMD (NSPR).

Which stock has performed better over the past year, MBOT or NSPR?

MBOT returned -62.84% over the past 12 months, compared with -72.02% for NSPR (price return, excluding dividends). Past performance does not predict future results.

Are Microbot Medical and InspireMD in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons